• Aligos Therapeutics issued non-qualified stock options covering 10,700 shares to newly hired employees on April 22, 2026.
• Exercise price was set at closing price of Aligos common stock on grant date.
• Award vests over four years, with 25% vesting on first anniversary of grant date.
• Remaining options vest in equal monthly installments, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604240800PRIMZONEFULLFEED9690879) on April 24, 2026, and is solely responsible for the information contained therein.